Sunvozertinib
Dizal Pharmaceuticals
['sunvozertinib', 'sclc', 'nsclc', 'dzd9008']
#sunvozertinib (dzd9008) for egfr exon 20 ins+ nsclc by dr. mengzhao wang. n=97. orr=60.8%. activity seen regardless of insertion locations. promising drug in egfr exon 20 space! #asco23 
Thoracic Medical Oncologist at Georgetown University | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM